ABSTRACT
Primary liver cancer is the fourth most common malignancy and the second most common cause of cancer death in China, which poses a serious threat to the life and health of the Chinese people. Hepatocellular carcinoma (HCC) represents more than 90% of the pathology of primary liver cancer, among them around 60% of patients are at the intermediate-advanced stage when diagnosed. Therefore, increasing the rate of resection via conversion therapies is particularly important to improve the prognosis of these patients. Vascular interventional therapies represented by transarterial chemoembolization and hepatic arterial infusion chemotherapy are important treatment methods for HCC patients in intermediate-advanced stage, showing good rates of tumor response and surgical conversion. Combined with research data at home and abroad, the authors analyze research progress of vascular interventional therapy in the conversion therapy of HCC, review the history and the strategies of conversion therapies based on vascular interventional therapy in this article.
ABSTRACT
Objective: To study the changes in coagulation function in patients with advanced tumors before and after vascular interventional therapy. Methods: A total of 174 patients with middle-late stage tumors undergoing oncology vascular interventional treatment at Beijing Hospital Of Traditional Chinese Medicine Affiliated With Capital Medical University, between January 2018 and October 2018 were included in this retrospective analysis. Changes in platelets (PLT) and related blood coagulation indicators were observed before and after vascular intervention. Among them, 63 patients who received relevant indicators detection within a week after vascular intervention were in group A, and 111 patients who received relevant indicators detection 1 month (30±7 days) after vascular intervention were in group B. SPSS version 22 software was used for statistical analysis. Results: In group A, fibrinogen (FIB) and D-dimer (D-D) values significantly increased, activated pattial thromboplastin timeAPITshortened, and PLT values decreased compared to those before treatment (all P0.05) than those before treatment. Before vascular interventional therapy, a total of 58 patients had hypercoagulability, including 28 patients in group A (48.3%) and 30 patients in group B (51.7%). In contrast, after vascular interventional therapy, a total of 71 (40.8%) patients had hypercoagulability, including 40 (56.3%) patients in group A and 31 (43.7%) patients in group B. Conclusions: Vascular interventional treatment can affect the related blood clotting index in the short term, which is intensified in patients with middle-late tumors and a high blood coagulation state. However, over time the coagulation state gradually mitigated and eventually returned to before-treatment levels. These findings suggest that patients' coagulation function should be closely monitored after intervention treatment.
ABSTRACT
Liver is one of the most predilection sites of hematogenous metastasis of a variety of malignances,especially for gastrointestinal tumors.Surgical resection was the first choice for the treatment of liver metastases,while it could not apply to patients who had multiple metastatic lesions or other organs involvement.Interventional technique has been widely recognized for the advantages of minimal trauma,little pain,quick recovery and obvious efficacy.